Skip to search formSkip to main contentSkip to account menu

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase

Known as: Polycythemia Vera, "Spent" Phase, Polycythemia Vera, Post-Polycythemic Myelofibrosis and Myeloid Metaplasia Stage 
Progression of polycythemia vera characterized by decreased erythropoiesis and granulopoiesis, reticulin and collagen fibrosis of the bone marrow… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Background: Primary/Post-Essential/Post-Polycythemic Myelofibrosis (MF) is characterized by impaired maturation of GATA1… 
2015
2015
BackgroundRuxolitinib, a novel inhibitor of Janus kinases 1 and 2, was recently approved for the treatment of myelofibrosis but… 
2015
2015
Dear Editor,Myelofibrosis (MF), either primary (PMF) or secondary topolycythemia vera (post-PV MF), is associated with a… 
2013
2013
Polycythemia vera and primary myelofibrosis share a propensity to progress toward a myelofibrotic late stage with overlapping… 
2012
2012
A clonal myeloproliferative neoplasm (MPN) of the hematopoietic stem cell, polycythemia vera (PV) involves increased red blood… 
2008
2008
Dear Editor, Procalcitonin (PCT) is a highly specific serum marker for the differential diagnosis in patients with systemic… 
Highly Cited
2003
Highly Cited
2003
Review
2000
Review
2000
  • A. Tefferi
  • New England Journal of Medicine
  • 2000
  • Corpus ID: 14172933
Myelofibrosis with myeloid metaplasia is classified broadly as a chronic myeloid disorder and, more specifically, as a chronic… 
Review
1999
Review
1999
The presence of a hemorheological disturbance must be considered in the pathophysiological and therapeutical approach to vascular…